The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of a reduced burden of therapy trial by incorporation of rituximab and intrathecal liposomal cytarabine in children, adolescents and young adults with intermediate (FAB Group B) and high risk (FAB Group C) mature B-cell lymphoma/leukemia.
 
Stanton Goldman
Speakers' Bureau - Jazz Pharmaceuticals
 
Matthew John Barth
No Relationships to Disclose
 
Javier E. Oesterheld
No Relationships to Disclose
 
Kenneth Heym
No Relationships to Disclose
 
Lauren Harrison
No Relationships to Disclose
 
Berkley Nickerson
No Relationships to Disclose
 
Nader El-Mallawany
No Relationships to Disclose
 
Jessica Hochberg
No Relationships to Disclose
 
Mitchell S. Cairo
Consulting or Advisory Role - Roche/Genentech